Gala Review

Gala in one line: a flat-rate, all-doses-included GLP-1 subscription that asks for a year up front

Gala (run by the Delaware company AI Coaching Inc., doing business as Gala GLP-1) sells compounded semaglutide and compounded tirzepatide on a yearly plan. The promise is simple: pay one flat monthly rate and every dose you ever titrate up to is included, with free shipping on top. If you already know you want a compounded GLP-1, hate surprise upcharges as your dose climbs, and are comfortable committing to a 12-month subscription, Gala is built squarely for you. If you want to go month-to-month or know exactly which pharmacy is making your medication, this is not the right fit.

How the pricing works: flat, but annual

Gala's headline structure is a flat yearly subscription where the price doesn't change as your dose increases. The company states plainly that 'if a higher dose is recommended, it will be available at no additional cost,' which removes the single biggest budgeting headache with GLP-1 therapy, since most providers charge more as you move up the titration ladder. The lowest listed price is compounded semaglutide from $129/mo (starting dose), and Gala doesn't say which plan length that figure assumes. For context, the category median is $179/mo.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 112 programs that publish one.

The flat rate is tied to a yearly commitment, and Gala does not publish a standalone month-to-month price. So the attractive number assumes you'll stay enrolled for 12 months. Read the cancellation terms before you sign. The site says you can cancel anytime and that provider support is included for as long as you're on the program, but the discount math is built around the annual plan. For readers who want to avoid a yearly plan, Live Vital sells its compounded GLP-1s as 10-week protocols you can cancel at any time. The catch: it doesn't name its pharmacy.

• Compounded tirzepatide (GLP-1/GIP): flat yearly subscription, all titration doses included
• Compounded semaglutide: from $129/mo (starting dose), plan length not stated
• Brand-name Ozempic: offered, but priced well above what peers charge for brand GLP-1s
• Free shipping and provider visits are bundled in, with no separate consult or delivery fees

The medications: two compounded molecules, plus brand Ozempic

Most compounded telehealth brands give you one molecule. Gala explicitly offers both compounded semaglutide and compounded tirzepatide, so you and your prescriber can pick the single-agonist or the dual GLP-1/GIP route without switching providers. Brand-name Ozempic is also on the menu for people who specifically want the FDA-approved pen, though Gala's brand price is noticeably higher than competitors who sell the same drug, so it's the weakest value in the lineup. An oral Wegovy pill is listed as 'coming soon' with pricing 'at launch,' meaning it is not something you can buy today.

What sets Gala apart

Two things. First, the no-upcharge-on-dose flat model is a clear differentiator. It's spelled out on the site, and it matters most for tirzepatide patients who expect to climb to higher doses. Second, the breadth: compounded sema, compounded tirz and brand Ozempic under one roof, with a claim of licensed providers in all 50 states and free nationwide shipping. Prescribing runs through licensed clinicians affiliated with OpenLoop medical groups, with Gala handling the technology and administrative side.

The trust gaps you should weigh

Gala displays a LegitScript seal and discloses HIPAA compliance, and there are no FDA warning letters on file for Gala GLP-1 or AI Coaching Inc. Those are points in its favor. But there are gaps. Gala does not name its compounding pharmacies and refers only to 'a wide network of pharmacies across all 50 states.' For a YMYL medical product, not knowing which facility mixes your injectable is a meaningful blind spot. A named pharmacy is where MEDVi stands out: it lists its partner pharmacies and offers compounded semaglutide tablets alongside brand-name Wegovy and Zepbound. The trade-off: it isn't available in Mississippi or North Dakota. The all-50-states claim is also gated behind the signup intake rather than published as a per-state list, which costs it points. You can read how we weigh these signals in our scoring methodology.

Who should choose Gala

• People who want flat, predictable pricing that won't rise as their dose increases
• Patients who want both compounded semaglutide and tirzepatide available from one provider
• Budget-focused starters drawn to compounded semaglutide from $129/mo (starting dose)
• Anyone who values bundled free shipping and an included provider visit

Who should skip it

• Anyone who wants a true month-to-month option without a yearly commitment
• Buyers who insist on knowing exactly which accredited pharmacy fills their prescription
• People shopping for brand Ozempic on price (Gala's brand rate is higher than peers)
• Anyone waiting on an oral GLP-1 today (the Wegovy pill is still 'coming soon')

Complaints, refunds & cancellation

Gala sells under the name Gala GLP-1 and is owned by AI Coaching, Inc. Its Cancellation and Refund Policy, last updated February 2026, starts billing when you finish the intake form. If a medical provider disqualifies you, you get a full refund. Outside that one case, the policy says in capital letters that no refund is issued when you cancel. Even an approved refund covers only your most recent billing cycle.

You can cancel at any time through customer service or your online account. The request must arrive at least 72 hours before your billing date. Miss that and the next charge goes through, with the cancellation taking effect a cycle later. You keep the service until the end of the cycle you paid for. Damaged or wrong medication is replaced by the pharmacy, so inspect each shipment when it arrives and write to team@galaglp1.com if anything is off. On Trustpilot, the profile listed as Gala Health showed 4.6 out of 5 from 4,255 reviews in October 2026, with 6% of them one-star.

Bottom line

Gala is a legitimate-looking, LegitScript-certified platform with a useful pricing idea: a flat yearly rate that covers every dose, plus compounded semaglutide from $129/mo (starting dose) against a $179/mo category median. For a committed patient who wants compounded semaglutide or tirzepatide without dose-based upcharges, it belongs on your shortlist. Just go in clear-eyed about the two trade-offs: the discount is built around a 12-month subscription, and Gala won't tell you which pharmacy makes your medication. If those don't bother you, it's a strong-value pick; if they do, compare it against providers that name their pharmacy and offer monthly billing.